1. Apollo Hospitals ready to administer 1 mn Covid vaccines daily  Social News XYZ
  2. Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60  Hindustan Times
  3. COVID-19 vaccine: WHO in talks with Russia on its second vaccine EpiVacCorona  Mint
  4. China's Sinopharm Offers Experimental COVID-19 Vaccines to Students  The Wire Science
  5. Covid-19: Most vulnerable 'could get vaccine by Christmas'  BBC News
  6. View Full coverage on Google News
Hyderabad, Oct 15 (SocialNews.XYZ) Leading private hospital group Apollo Hospitals on Thursday that it is prepared to administer one million Covid-19 vaccines per day whenever the vaccine is rolled out. The group said it will... - Social News XYZHyderabad, Oct 15 (SocialNews.XYZ) Leading private hospital group Apollo Hospitals on Thursday that it is prepared to administer one million Covid-19 [...]

Apollo Hospitals ready to administer 1 mn Covid vaccines daily - Social News XYZ

China has said that while reasonable profits for companies are permitted, covid-19 vaccines should be priced close to cost.Chinese authorities have to date not released pricing details for potential covid-19 vaccinesChina has said that while reasonable profits for companies are permitted, covid-19 vaccines should be priced close to cost.Chinese authorities have to date not released pricing details for potential covid-19 vaccines

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

Apollo Hospitals will deliver up to 10 lakh Covid-19 vaccines daily by leveraging its pan-India medical infrastructure, the group said. The hospital chain has 19 medicine supply hubs with cold chain facilities, 70 hospitals, over 400 clinics, 500 corporate health centres and 4,000 pharmacies, besides a digital platform. Apollo Hospitals will deliver up to 10 lakh Covid-19 vaccines daily by leveraging its pan-India medical infrastructure, the group said. The hospital chain has 19 medicine supply hubs with cold chain

Apollo Hospitals to deliver up to 10 lakh Covid-19 vaccines daily across India | Deccan Herald

The second phase of the study was designed to identify the optimal timing schedule for vaccination.The second phase of the study was designed to identify the optimal timing schedule for vaccination.

Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.

Coronavirus: Experimental £46 COVID-19 vaccine is made available to residents of Chinese city | Daily Mail Online

Treatment is safe and elicits an antibody response, preliminary results have shownTreatment is safe and elicits an antibody response, preliminary results have shown

'Enouraging' Chinese Covid vaccine shows early promise - Hull Live

403 Missing Auth Token

Coronavirus vaccine update: The International Monetary Fund (IMF) has said that international cooperation on a coronavirus vaccine could boost the global economy by $9 trillion to pull it out of the economic crisis. Meanwhile, in the global vaccine race, a Chinese vaccine has shown positive results in the human test.Coronavirus vaccine update: The International Monetary Fund (IMF) has said that international cooperation on a coronavirus vaccine could boost the global economy by $9 trillion to pull it out of the economic crisis. Meanwhile, in the global vaccine race, a Chinese vaccine has shown positive results in the human test.

Coronavirus vaccine update: Chinese vaccine shows positive results, US probing Vaxart claims - Coronavirus Outbreak News

The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.

Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

The group says they have also built the largest cold chain network and distribution system to safely transport and store vaccine

Apollo ready to administer 1 million COVID-19 vaccines a day

The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study

50 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-1950 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-19

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm | Africanews

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

China rapidly expands use of experimental COVID-19 vaccines | World News,The Indian Express

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

China rapidly expands use of experimental COVID-19 vaccines | World News,The Indian Express

The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec GrThe potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec Gr

Coronavirus vaccine candidate from China's CNBG shows promise in human test, study shows - Times of India

The move is aimed at boosting public confidence in homegrown inoculations, the WSJ reported, citing a company website and some students who applied for it.

China's Sinopharm Offers Experimental COVID-19 Vaccines to Students - The Wire Science

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

Leading private hospital group Apollo Hospitals on Thursday that it is prepared to administer one million Covid-19 vaccines per day whenever the vaccine is rolled out.Leading private hospital group Apollo Hospitals on Thursday that it is prepared to administer one million Covid-19 vaccines per day whenever the vaccine is rolled out.

Apollo Hospitals ready to administer 1 mn Covid vaccines daily | greatandhra.com

THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.

Queen news: Queen could play key role if coronavirus vaccine becomes available - expert | Royal | News | Express.co.uk

The market leader in flu vaccines is trailing in the race to find an effective coronavirus vaccine.The market leader in flu vaccines is trailing in the race to find an effective coronavirus vaccine.

Sanofi and Translate Bio Have a COVID-19 Vaccine Candidate Ready for Clinical Trials | The Motley Fool

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial ...

Preliminary results find COVID-19 vaccine candidate based on inactivated SARS-CoV-2 virus is safe

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

China is positioning itself to be key to any global solution to the pandemic.. Read more at straitstimes.com.East Asia News -China is positioning itself to be key to any global solution to the pandemic.. Read more at straitstimes.com.

Beijing in Covid-19 vaccine race to restore international image, East Asia News & Top Stories - The Straits Times

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

China has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said theChina has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said the

NO side effects have been recorded thus far, as the development of the Covid-19 vaccine between Indonesia and China progresses.

Indonesia-China vaccine trials run smoothly | New Straits Times

Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine.Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine.

Chinese Covid-19 vaccine candidate 'safely triggers antibody response' | ITV News

Officials in Jiaxing city said residents with urgent needs can seek vaccination in the first mass roll-out.Officials in Jiaxing city said residents with urgent needs can seek vaccination in the first mass roll-out.

Covid-19: China rolls out $60 experimental vaccine for residents - News | Khaleej Times

Hope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet Infectious Disease, is based on small early phase randomised clinical trials involving 640 participants. The vaccine candidate is based on inactivated coronavirus. Scientists said thoseHope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet

Hope for coronavirus vaccine boosted as scientists say Chinese jab safe and produces immune response | London Evening Standard

BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...

US$60 experimental COVID-19 vaccine rolled out in east Chinese city - CNA

Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59

Preliminary results show Chinese Covid-19 vaccine candidate safe | Dhaka Tribune

Sanofi and its partner Translate Bio tested their mRNA COVID-19 vaccine candidate MRT5500 in mice and macaques and found that the animals developed neutralizing antibodies and a favorable T-cell response, they reported. A phase 1/2 trial is expected to start this quarter.Sanofi and its partner Translate Bio tested their mRNA COVID-19 vaccine candidate MRT5500 in mice and macaques and found that the animals developed neutralizing antibodies and a favorable T-cell response, they reported. A phase 1/2 trial is expected to start this quarter.

COVID-19 mRNA vaccine candidate from Sanofi and Translate protects mice, monkeys: study | FierceBiotech

Fresh hope of a Covid-19 vaccine has emerged from a new trial showing an experimental Chinese jab is "safe and elicits an antibody response" to fight the virus.Fresh hope of a Covid-19 vaccine has emerged from a new trial showing an experimental Chinese jab is "safe and elicits an antibody response" to fight the virus.

Chinese vaccine trial offers fresh hope in war against pandemic - Independent.ie

The Indonesian government has secured a supply of those vaccines, including 143 million doses of Sinovac vaccineThe Indonesian government has secured a supply of those vaccines, including 143 million doses of Sinovac vaccine

Indonesian Team in China for Covid-19 Vaccine Safety Audit

Clinical trials of the coronavirus vaccine have involved 640 peopleClinical trials of the coronavirus vaccine have involved 640 people

Chinese Covid-19 vaccine candidate safe, early reports say | Metro News

This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.

China's Covid-19 vaccine candidate is safe and prompts antibody response - early results from study

A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...

€50 experimental COVID-19 vaccine rolled out in east Chinese city

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

The website said on Monday that 481,613 people had taken the vaccine while an additional 93,653 had applied to be inoculated, according to the report.The website said on Monday that 481,613 people had taken the vaccine while an additional 93,653 had applied to be inoculated, according to the report.

China’s Sinopharm offers experimental Covid-19 vaccines to students: report | coronavirus outbreak News,The Indian Express

The website said on Monday that 481,613 people had taken the vaccine while an additional 93,653 had applied to be inoculated, according to the report.The website said on Monday that 481,613 people had taken the vaccine while an additional 93,653 had applied to be inoculated, according to the report.

China’s Sinopharm offers experimental Covid-19 vaccines to students: report | coronavirus outbreak News,The Indian Express